Dr. Holger Reithinger
Forbion
Picture: FCPM III Services B.V.
Symposia
Conference room: Saal 2
When to invest, how much and in whom? What characterizes a promising company? What are the most important criteria for investing and have these changed in the past years? Venture capitalists discuss their strategies to cope with the competition and the development potential of their portfolio biotech start-ups. The discussion will be complemented with a perspective from a seasoned biotech CEO.